Journal of the National Comprehensive Cancer Network : JNCCN · 2014
Hepatobiliary cancers, version 2.2014.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Benson Al B, D'Angelica Michael I, Abrams Thomas A, Are Chandrakanth, Bloomston P Mark, Chang Daniel T, Clary Bryan M, Covey Anne M, Ensminger William D, Iyer Renuka, Kelley R Kate, Linehan David, Malafa Mokenge P, Meranze Steven G, Park James O, Pawlik Timothy, Posey James A, Scaife Courtney, Schefter Tracey, Sigurdson Elin R, Tian G Gary, Vauthey Jean-Nicolas, Venook Alan P, Yen Yun, Zhu Andrew X, Hoffmann Karin G, McMillian Nicole R, Sundar Hema
Аннотация
Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma), gall bladder, and bile ducts (cholangiocarcinomas). Gallbladder cancer and cholangiocarcinomas are collectively known as biliary tract cancers. Gallbladder cancer is the most common and aggressive type of all the biliary tract cancers. Cholangiocarcinomas are diagnosed throughout the biliary tree and are typically classified as either intrahepatic or extrahepatic cholangiocarcinoma. Extrahepatic cholangiocarcinomas are more common than intrahepatic cholangiocarcinomas. This manuscript focuses on the clinical management of patients with gallbladder cancer and cholangiocarcinomas (intrahepatic and extrahepatic).